ONTOLOGY REPORT - ANNOTATIONS
| Term: | abnormal blood homeostasis |
|
| Accession: | MP:0009642
|
browse the term
|
| Definition: | anomaly in the processes involved in the maintenance of an internal equilibrium of various functions or chemical or protein composition of the blood |
| Synonyms: | exact_synonym: | abnormal blood chemistry; blood chemistry abnormalities |
| | alt_id: | MP:0000179; MP:0001546 |
|
|
abnormal blood coagulation
|
| G |
Ggcx |
gamma-glutamyl carboxylase |
|
|
IEA |
4 |
105,719,323 |
105,735,037 |
RGD:704404 |
RGD |
abnormal circulating cholesterol level
|
| Q |
Scl30 |
Serum cholesterol level QTL 30 |
|
|
QTM |
7 |
21,790,655 |
53,398,255 |
RGD:1302893 |
RGD |
| Q |
Scl31 |
Serum cholesterol level QTL 31 |
|
|
QTM |
17 |
26,570,057 |
71,570,057 |
RGD:1302893 |
RGD |
| S |
SHR/Mol |
|
|
|
QTM |
|
|
|
RGD:619667 |
RGD |
abnormal circulating corticosterone level
|
| Q |
Scort1 |
Serum corticosterone level QTL 1 |
|
|
QTM |
1 |
159,782,445 |
263,699,089 |
RGD:1302893 |
RGD |
abnormal circulating creatinine level
|
| Q |
Rf19 |
Renal function QTL 19 |
|
|
QTM |
11 |
41,711,171 |
84,560,241 |
RGD:727992 |
RGD |
| Q |
Rf24 |
Renal function QTL 24 |
|
|
QTM |
16 |
3,464,719 |
22,979,073 |
RGD:727992 |
RGD |
| Q |
Rf25 |
Renal function QTL 25 |
|
|
QTM |
17 |
82,277,326 |
92,594,341 |
RGD:727992 |
RGD |
| Q |
Rf46 |
Renal function QTL 46 |
|
|
QTM |
1 |
103,149,923 |
154,075,310 |
RGD:1302893 |
RGD |
| Q |
Rf48 |
Renal function QTL 48 |
|
|
QTM |
2 |
75,806,326 |
214,989,298 |
RGD:1302893 |
RGD |
| Q |
Rf49 |
Renal function QTL 49 |
|
|
QTM |
17 |
1 |
81,039,660 |
RGD:1302893 |
RGD |
| Q |
Stl7 |
Serum triglyceride level QTL 7 |
|
|
QTM |
11 |
29,744,366 |
84,560,241 |
RGD:727992 |
RGD |
abnormal circulating free fatty acids level
|
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
|
IPM |
4 |
13,471,878 |
13,525,620 |
RGD:68930 |
RGD |
| G |
Cd36 |
CD36 molecule (thrombospondin receptor) |
|
|
IPM |
4 |
13,471,878 |
13,525,620 |
RGD:1600636 |
RGD |
abnormal circulating HDL cholesterol level
|
| Q |
Scl32 |
Serum cholesterol level QTL 32 |
|
|
QTM |
17 |
26,570,057 |
71,570,057 |
RGD:1302893 |
RGD |
abnormal circulating insulin level
|
| G |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
|
|
IED |
10 |
83,043,636 |
83,112,886 |
RGD:68746 |
RGD |
| Q |
Insul1 |
Insulin level QTL 1 |
|
|
QTM |
17 |
9,988,620 |
81,039,660 |
RGD:1302893 |
RGD |
| S |
CRDH |
Cohen Rosenthal Diabetic Hypertensive |
|
|
IED |
|
|
|
RGD:724741 |
RGD |
abnormal circulating interleukin-6 level
|
| Q |
Apr3 |
Acute phase response QTL 3 |
|
|
IED |
10 |
16,579,339 |
61,579,339 |
RGD:629561 |
RGD |
| Q |
Apr5 |
Acute phase response QTL 5 |
|
|
IED |
12 |
568,621 |
45,568,621 |
RGD:629561 |
RGD |
| Q |
Apr6 |
Acute phase response QTL 6 |
|
|
IED |
14 |
1 |
42,665,455 |
RGD:629561 |
RGD |
abnormal circulating LDL cholesterol level
|
| Q |
Spl5 |
Serum phospholipid level QTL 5 |
|
|
QTM |
7 |
21,790,655 |
56,589,443 |
RGD:1302893 |
RGD |
abnormal circulating lipid level
|
| S |
LH-Chr 13BN/MavRrrc |
|
|
|
TAS |
|
|
|
RGD:2292495 |
RGD |
| S |
LH-Chr 17BN/MavRrrc |
|
|
|
TAS |
|
|
|
RGD:2292495 |
RGD |
abnormal circulating phospholipid level
|
| Q |
Spl4 |
Serum phospholipid level QTL 4 |
|
|
QTM |
7 |
21,790,655 |
53,398,255 |
RGD:1302893 |
RGD |
| Q |
Spl7 |
Serum phospholipid level QTL 7 |
|
|
QTM |
17 |
26,570,057 |
71,570,057 |
RGD:1302893 |
RGD |
abnormal circulating renin level
|
| Q |
Rf47 |
Renal function QTL 47 |
|
|
QTM |
13 |
32,030,139 |
105,788,017 |
RGD:1302893 |
RGD |
| Q |
Srn5 |
Serum renin concentration QTL 5 |
|
|
IAGP |
4 |
115,896,404 |
160,896,404 |
RGD:70849 |
RGD |
| Q |
Srn6 |
Serum renin concentration QTL 6 |
|
|
QTM |
5 |
71,971,592 |
157,597,184 |
RGD:1302893 |
RGD |
abnormal circulating serum amyloid protein level
|
| S |
F344-Tg(APPswe)Opaz |
|
|
|
IED |
|
|
|
RGD:2292518 |
RGD |
abnormal circulating VLDL cholesterol level
|
| Q |
Spl6 |
Serum phospholipid level QTL 6 |
|
|
QTM |
17 |
26,570,057 |
71,570,057 |
RGD:1302893 |
RGD |
| Q |
Spl8 |
Serum phospholipid level QTL 8 |
|
|
QTM |
17 |
1 |
71,570,057 |
RGD:1302893 |
RGD |
abnormal hemostasis
|
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
|
IMP |
10 |
67,134,790 |
67,155,891 |
RGD:4889487 |
RGD |
abnormal platelet physiology
|
| S |
SHR.F344-(D12Mgh5-D12Mgh6)/Snk |
|
|
|
IED |
12 |
29,130,180 |
42,387,195 |
RGD:1599588 |
RGD |
atrial thrombosis
|
| S |
SHR.F344-(D12Mgh5-D12Mgh6)/Snk |
|
|
|
IED |
12 |
29,130,180 |
42,387,195 |
RGD:1599588 |
RGD |
decreased circulating aldosterone level
|
| S |
LEW/OlaHsd |
|
|
|
QTM |
|
|
|
RGD:629577 |
RGD |
| S |
LH/Mav |
|
|
|
TAS |
|
|
|
RGD:1302893 |
RGD |
decreased circulating antidiuretic hormone level
|
| S |
RHA/N-di |
Roman high avoidance-di mutation |
|
|
IED |
|
|
|
RGD:2314670 |
RGD |
decreased circulating calcium level
|
| S |
LH/Mav |
|
|
|
TAS |
|
|
|
RGD:1302893 |
RGD |
decreased circulating cholesterol level
|
| Q |
Niddm59 |
Non-insulin dependent diabetes mellitus QTL 59 |
|
|
IED |
1 |
248,583,506 |
266,234,812 |
RGD:734465 |
RGD |
| Q |
Scl1 |
Serum cholesterol level QTL 1 |
|
|
QTM |
15 |
18,710,622 |
87,898,700 |
RGD:61092 |
RGD |
| Q |
Scl2 |
Serum cholesterol level QTL 2 |
|
|
QTM |
5 |
62,098,646 |
149,757,440 |
RGD:61092 |
RGD |
| Q |
Scl20 |
Serum cholesterol QTL 20 |
|
|
QTM |
5 |
86,116,638 |
172,913,795 |
RGD:1299960 |
RGD |
| Q |
Scl21 |
Serum cholesterol QTL 21 |
|
|
QTM |
12 |
7,754,826 |
25,802,539 |
RGD:1299960 |
RGD |
| Q |
Scl3 |
Serum cholesterol level QTL 3 |
|
|
QTM |
7 |
95,054,656 |
132,141,292 |
RGD:61092 |
RGD |
| Q |
Scl59 |
Serum cholesterol level QTL 59 |
|
Induced |
IED |
14 |
79,256,324 |
107,101,727 |
RGD:2300117 |
RGD |
| S |
BN/Seac |
|
|
|
IED |
|
|
|
RGD:2300117 |
RGD |
| S |
EHC.BN-(D14Rat43-D14Rat132)/Kyu |
|
|
Induced |
IED |
14 |
79,256,324 |
107,101,727 |
RGD:2300117 |
RGD |
| S |
LEW/OlaHsd |
|
|
|
QTM |
|
|
|
RGD:629577 |
RGD |
| S |
LEW/OlaHsd |
|
|
|
IED |
|
|
|
RGD:629577 |
RGD |
| S |
LH-Chr 13BN/Mav |
|
|
Induced |
IED |
|
|
|
RGD:2313340 |
RGD |
| S |
LN/Mav |
|
|
|
IED |
|
|
|
RGD:1580389 |
RGD |
| S |
MWF-Chr 6SHR/Rkb |
|
|
|
IED |
|
|
|
RGD:1600609 |
RGD |
| S |
OLETF.F344-(D1Rat306-D1Rat461)/Got |
|
|
|
IED |
1 |
248,583,506 |
266,234,812 |
RGD:734465 |
RGD |
| S |
SHRSP/A3 |
|
|
|
TAS |
|
|
|
RGD:61092 |
RGD |
| S |
SR/Hsd |
|
|
|
QTM |
|
|
|
RGD:737694 |
RGD |
| S |
SS-Chr 19SHR/Rkb |
|
|
Induced |
IED |
|
|
|
RGD:2307185 |
RGD |
| S |
WOKW |
|
|
|
QTM |
|
|
|
RGD:1357168 |
RGD |
decreased circulating corticosterone level
|
| Q |
Scort2 |
Serum corticosterone level QTL 2 |
|
|
IED |
1 |
80,851,478 |
125,851,478 |
RGD:4889455 |
RGD |
| Q |
Srcrt2 |
Stress Responsive Cort QTL 2 |
|
|
IED |
3 |
35,237,920 |
134,686,096 |
RGD:1598980 |
RGD |
| Q |
Srcrt4 |
Stress Responsive Cort QTL 4 |
|
|
IED |
6 |
104,481,235 |
123,455,207 |
RGD:1598980 |
RGD |
| S |
LEW/NIcoCrlf |
|
|
|
TAS |
|
|
|
RGD:1598975 |
RGD |
| S |
WAG |
|
|
|
IED |
|
|
|
RGD:2306974 |
RGD |
| S |
WKY/NHsd |
|
|
|
IED |
|
|
|
RGD:1598980 |
RGD |
| S |
WMI/Eer |
WKY most immobile |
|
|
IED |
|
|
|
RGD:4891104 |
RGD |
decreased circulating creatinine level
|
| S |
SBN-Chr 17SBH/Ygl |
|
|
|
IED |
|
|
|
RGD:629619 |
RGD |
| S |
SBN-Chr 1SBH/Ygl |
|
|
|
IED |
|
|
|
RGD:629619 |
RGD |
decreased circulating estradiol level
|
| G |
Crh |
corticotropin releasing hormone |
|
|
IED |
2 |
104,764,023 |
104,765,887 |
RGD:704424 |
RGD |
decreased circulating free fatty acid level
|
| G |
Adora1 |
adenosine A1 receptor |
|
|
IED |
13 |
47,160,292 |
47,192,804 |
RGD:1625243 |
RGD |
| Q |
Kidm1 |
Kidney mass QTL 1 |
|
|
QTM |
1 |
219,804,771 |
259,173,490 |
RGD:634617 |
RGD |
| Q |
Kidm2 |
Kidney mass QTL 2 |
|
|
QTM |
18 |
62,739,615 |
87,265,094 |
RGD:634617 |
RGD |
| Q |
Kidm3 |
Kidney mass QTL 3 |
|
|
QTM |
19 |
31,224,173 |
59,218,465 |
RGD:634617 |
RGD |
decreased circulating glucose level
|
| G |
Adora1 |
adenosine A1 receptor |
|
|
IED |
13 |
47,160,292 |
47,192,804 |
RGD:1625365 |
RGD |
| G |
Crh |
corticotropin releasing hormone |
|
|
IED |
2 |
104,764,023 |
104,765,887 |
RGD:704397 |
RGD |
| G |
Gcgr |
glucagon receptor |
|
|
IEA |
10 |
109,921,411 |
109,929,577 |
RGD:704404 |
RGD |
| G |
Gck |
glucokinase |
|
|
IED |
14 |
86,572,518 |
86,587,723 |
RGD:2301945 |
RGD |
| G |
Glp1r |
glucagon-like peptide 1 receptor |
|
Not |
IED |
20 |
9,225,881 |
9,264,184 |
RGD:625448 |
RGD |
| G |
Retn |
resistin |
|
|
IEA |
12 |
2,499,630 |
2,501,370 |
RGD:704404 |
RGD |
| Q |
Bw118 |
Body weight QTL 118 |
|
|
IAGP |
6 |
34,039,461 |
59,946,628 |
RGD:619678 |
RGD |
| Q |
Gluco41 |
Glucose level QTL 41 |
|
|
IED |
1 |
103,483,490 |
148,483,490 |
RGD:2312611 |
RGD |
| Q |
Gluco44 |
Glucose level QTL 44 |
|
|
IED |
12 |
13,948,769 |
46,782,294 |
RGD:2312611 |
RGD |
| Q |
Gluco46 |
Glucose level QTL 46 |
|
|
IED |
3 |
25,754,538 |
70,754,538 |
RGD:2312611 |
RGD |
| Q |
Gluco52 |
Glucose level QTL 52 |
|
|
IED |
|
|
|
RGD:2312611 |
RGD |
| Q |
Iddm15 |
Insulin dependent diabetes mellitus QTL 15 |
|
|
IAGP |
|
|
|
RGD:619685 |
RGD |
| Q |
Niddm49 |
Non-insulin dependent diabetes mellitus QTL 49 |
|
|
QTM |
10 |
92,782,172 |
101,848,683 |
RGD:619678 |
RGD |
| S |
CDS-Chr 4CDR/Ygl |
|
|
|
IED |
|
|
|
RGD:2326163 |
RGD |
| S |
OLETF.F344-(D1Rat306-D1Rat461)/Got |
|
|
|
IED |
1 |
248,583,506 |
266,234,812 |
RGD:734465 |
RGD |
| S |
WOKW |
|
|
|
QTM |
|
|
|
RGD:1357168 |
RGD |
decreased circulating glycerol level
|
| G |
Adora1 |
adenosine A1 receptor |
|
|
IED |
13 |
47,160,292 |
47,192,804 |
RGD:1625243 |
RGD |
decreased circulating HDL cholesterol level
|
| S |
BN.PD-(D8Rat39-D8Rat35),SHR-(D2Mit4-D2Rat28),SHR-(D2Rat103-D2Rat107)/Cub |
|
|
|
IED |
|
|
|
RGD:1580751 |
RGD |
| S |
SHR-Chr YBN/Cub |
|
|
Induced |
IED |
|
|
|
RGD:619661 |
RGD |
| S |
SHR.BN-(D13Arb5-Ren1)/Ipcv |
|
|
|
IED |
13 |
38,985,717 |
46,275,213 |
RGD:61512 |
RGD |
| S |
SR/Hsd |
|
|
|
QTM |
|
|
|
RGD:737694 |
RGD |
| S |
SS-Tg(ApoC3-CETP)53Opaz |
|
|
|
IED |
|
|
|
RGD:2290427 |
RGD |
| S |
WOKW |
|
|
|
QTM |
|
|
|
RGD:1357168 |
RGD |
decreased circulating insulin level
|
| Q |
Gluco16 |
Glucose level QTL 16 |
|
|
QTM |
4 |
1 |
25,671,721 |
RGD:61078 |
RGD |
| Q |
Gluco17 |
Glucose level QTL 17 |
|
|
QTM |
12 |
1 |
12,240,883 |
RGD:61078 |
RGD |
| Q |
Gluco32 |
Glucose level QTL 32 |
|
|
IED |
4 |
34,206,019 |
41,729,771 |
RGD:1626640 |
RGD |
| Q |
Gluco61 |
Glucose level QTL 61 |
|
|
IED |
4 |
34,206,019 |
38,029,988 |
RGD:2326163 |
RGD |
| Q |
Gluco62 |
Glucose level QTL 62 |
|
|
IED |
11 |
56,625,258 |
67,465,962 |
RGD:2326163 |
RGD |
| Q |
Gluco63 |
Glucose level QTL 63 |
|
|
IED |
13 |
84,280,242 |
111,154,910 |
RGD:2326163 |
RGD |
| Q |
Iddm16 |
Insulin dependent diabetes mellitus QTL 16 |
|
|
QTM |
|
|
|
RGD:61077 |
RGD |
| Q |
Iddm8 |
Insulin dependent diabetes mellitus QTL 8 |
|
|
QTM |
6 |
110,581,307 |
147,636,619 |
RGD:61077 |
RGD |
| Q |
Insul2 |
Insulin level QTL 2 |
|
|
QTM |
20 |
6,880,472 |
18,245,770 |
RGD:69703 |
RGD |
| Q |
Insul22 |
Insulin level QTL 22 |
|
|
IAGP |
4 |
23,537,363 |
74,625,985 |
RGD:1626640 |
RGD |
| Q |
Niddm43 |
Non-insulin dependent diabetes mellitus QTL 43 |
|
|
QTM |
1 |
204,280,278 |
267,111,153 |
RGD:619688 |
RGD |
| Q |
Niddm44 |
Non-insulin dependent diabetes mellitus QTL 44 |
|
|
QTM |
1 |
43,872,827 |
204,280,278 |
RGD:619688 |
RGD |
| Q |
Niddm58 |
Non-insulin dependent diabetes mellitus QTL 58 |
|
|
IAGP |
1 |
230,411,091 |
267,593,558 |
RGD:619683 |
RGD |
| S |
BB/N |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
BBDP/WorN |
|
|
|
IED |
|
|
|
RGD:1578691 |
RGD |
| S |
DA/K |
Dark Agouti/Karlsburg |
|
|
QTM |
|
|
|
RGD:1357168 |
RGD |
| S |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
|
|
|
QTM |
1 |
267,110,921 |
267,111,153 |
RGD:619688 |
RGD |
| S |
F344.GK-(D1Got251-D1Gpam-1)/Swe |
|
|
|
IED |
1 |
260,641,680 |
260,641,846 |
RGD:2316628 |
RGD |
| S |
F344.GK-(D1Swe8-D1Gpam-1)/Swe |
|
|
|
IED |
1 |
259,866,528 |
259,866,737 |
RGD:2316628 |
RGD |
| S |
GK/KyoSwe |
Goto Kakizaki |
|
|
QTM |
|
|
|
RGD:61061 |
RGD |
| S |
GK/MolTac |
Goto-Kakizaki |
|
|
TAS |
|
|
|
RGD:1559308 |
RGD |
| S |
GK/Ox |
|
|
|
IED |
|
|
|
RGD:4889455 |
RGD |
| S |
LN/Mav |
|
|
|
IED |
|
|
|
RGD:1580389 |
RGD |
| S |
SD-Tg(Ins2-IAPP)Soel |
|
|
|
IED |
|
|
|
RGD:2313576 |
RGD |
| S |
SD/Rij |
|
|
|
IED |
|
|
|
RGD:628479 |
RGD |
| S |
SDT/CrljJcl |
|
|
|
IED |
|
|
|
RGD:628479 |
RGD |
| S |
ZDF |
Vancouver diabetic fatty Zucker |
|
|
IED |
|
|
|
RGD:68896 |
RGD |
decreased circulating LDL cholesterol level
|
| S |
SR/Hsd |
|
|
|
QTM |
|
|
|
RGD:737694 |
RGD |
decreased circulating leptin level
|
| G |
Gcgr |
glucagon receptor |
|
|
IEA |
10 |
109,921,411 |
109,929,577 |
RGD:704404 |
RGD |
| G |
Mstn |
myostatin |
|
|
IEA |
9 |
45,426,831 |
45,431,658 |
RGD:704404 |
RGD |
| S |
DA/K |
Dark Agouti/Karlsburg |
|
|
QTM |
|
|
|
RGD:1357168 |
RGD |
decreased circulating luteinizing hormone level
|
| S |
LAA/FDSC |
Hatano Low Avoidance |
|
|
TAS |
|
|
|
RGD:1300227 |
RGD |
decreased circulating noradrenaline level
|
| S |
SHRSP.WKY-(D1Smu13-D1Wox33)/Izm |
|
|
Induced |
IAGP |
1 2 |
160,754,901 198,300,754 |
160,755,065 198,300,855 |
RGD:4889147 |
RGD |
decreased circulating phospholipid level
|
| S |
LEW/OlaHsd |
|
|
|
QTM |
|
|
|
RGD:629577 |
RGD |
| S |
LN/Mav |
|
|
|
IED |
|
|
|
RGD:1580389 |
RGD |
decreased circulating progesterone level
|
| G |
Crh |
corticotropin releasing hormone |
|
|
IED |
2 |
104,764,023 |
104,765,887 |
RGD:704424 |
RGD |
decreased circulating prolactin level
|
| S |
ACI.COP-(D3Rat130-D3Rat114)/Shul |
|
|
Induced |
IED |
3 |
44,551,252 |
149,496,698 |
RGD:2292503 |
RGD |
| S |
ACI.COP-(D6Rat80-D6Rat146)/Shul |
|
|
Induced |
IED |
6 |
16,302,145 |
16,302,283 |
RGD:2292503 |
RGD |
decreased circulating renin level
|
| Q |
Srn6 |
Serum renin concentration QTL 6 |
|
|
IAGP |
5 |
71,971,592 |
157,597,184 |
RGD:1302893 |
RGD |
| S |
LH/Mav |
|
|
|
TAS |
|
|
|
RGD:1302893 |
RGD |
| S |
SS/JrHsdMcwi |
|
|
|
TAS |
|
|
|
RGD:2289092 |
RGD |
decreased circulating serum albumin level
|
| G |
Alb |
albumin |
|
|
IAGP |
14 |
19,126,935 |
19,142,214 |
RGD:734959 |
RGD |
decreased circulating thyroid-stimulating hormone level
|
| S |
WIC-TgrdwKts |
|
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
decreased circulating triglyceride level
|
| G |
Adora1 |
adenosine A1 receptor |
|
|
IED |
13 |
47,160,292 |
47,192,804 |
RGD:1625243 |
RGD |
| Q |
Niddm58 |
Non-insulin dependent diabetes mellitus QTL 58 |
|
|
IED |
1 |
230,411,091 |
267,593,558 |
RGD:619683 |
RGD |
| S |
BN/Seac |
|
|
|
IED |
|
|
|
RGD:2300117 |
RGD |
| S |
DA/K |
Dark Agouti/Karlsburg |
|
|
QTM |
|
|
|
RGD:1357168 |
RGD |
| S |
MWF-Chr 6SHR/Rkb |
|
|
|
IED |
|
|
|
RGD:1600609 |
RGD |
| S |
SDT.ZDF-Leprfa/Jtt |
SDT fatty |
|
|
IED |
|
|
|
RGD:2314022 |
RGD |
| S |
SHR.PD-(D8Rat42-D8Arb23)/Cub |
|
|
|
IED |
8 |
51,376,771 |
52,822,796 |
RGD:1580747 |
RGD |
| S |
SR/Hsd |
|
|
|
QTM |
|
|
|
RGD:737694 |
RGD |
hyperglycemia
|
| Q |
Iddm20 |
Insulin dependent diabetes mellitus QTL 20 |
|
|
IAGP |
17 |
19,877,005 |
27,819,082 |
RGD:1358924 |
RGD |
| Q |
Iddm21 |
Insulin dependent diabetes mellitus QTL 21 |
|
|
IAGP |
|
|
|
RGD:1547853 |
RGD |
| Q |
Iddm22 |
Insulin dependent diabetes mellitus QTL 22 |
|
|
IAGP |
|
|
|
RGD:1547853 |
RGD |
| Q |
Iddm23 |
Insulin dependent diabetes mellitus QTL 23 |
|
|
IAGP |
|
|
|
RGD:1547853 |
RGD |
| S |
CD |
Cohen diabetic rat |
|
|
QTM |
|
|
|
RGD:1354520 |
RGD |
| S |
F344.GK-(D1Mgh10-D1Rat119)/Swe |
|
|
|
IED |
1 |
204,280,278 |
242,586,311 |
RGD:619677 |
RGD |
| S |
LEW.1AR1-iddm/Ztm |
|
|
|
IAGP |
|
|
|
RGD:1547853 |
RGD |
| S |
OLETF/Got |
Otsuka Long Evans Tokushima |
|
|
IED |
|
|
|
RGD:619679 |
RGD |
| S |
SDT/Jcl |
|
|
|
TAS |
|
|
|
RGD:631173 |
RGD |
hyperlipidemia
|
| Q |
Spl2 |
Serum phospholipid level QTL 2 |
|
|
QTM |
|
|
|
RGD:629577 |
RGD |
| S |
BN-Lx |
|
|
|
QTM |
|
|
|
RGD:61079 |
RGD |
| S |
HTG |
Prague hypertriglyceridemic |
|
|
TAS |
|
|
|
RGD:1299960 |
RGD |
| S |
LA/NJcr-cp |
JCR:LA-corpulent rat |
|
|
TAS |
|
|
|
RGD:1642389 |
RGD |
| S |
LH/Mav |
|
|
|
IED |
|
|
|
RGD:1580389 |
RGD |
| S |
LH/MavRrrc |
Lyon Hypertensive |
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
SHR/Ola |
|
|
|
QTM |
|
|
|
RGD:61079 |
RGD |
| S |
SS/Hsd |
|
|
|
TAS |
|
|
|
RGD:737694 |
RGD |
| S |
SS/Jr |
Salt Sensitive |
|
|
TAS |
|
|
|
RGD:727992 |
RGD |
| S |
SS/JrHsdMcwi |
|
|
|
TAS |
|
|
|
RGD:727992 |
RGD |
| S |
WBN |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
ZUC-Lepr+Ste |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
ZUC-LeprfaSte |
|
|
|
IED |
|
|
|
RGD:628581 |
RGD |
| S |
ZUC-LeprfaSteJrpz |
|
|
|
IED |
|
|
|
RGD:628436 |
RGD |
| S |
ZUC-LeprfaSteJrpz |
|
|
|
TAS |
|
|
|
RGD:628436 |
RGD |
increased bleeding time
|
| G |
Lyst |
lysosomal trafficking regulator |
|
|
IAGP |
17 |
66,569,478 |
66,735,402 |
RGD:1302441 |
RGD |
| S |
TM |
Tester Moriyama rat |
|
|
IED |
|
|
|
RGD:1302447 |
RGD |
| S |
TM/Kyo |
tester moriyama rat |
|
|
IED |
|
|
|
RGD:1302447 |
RGD |
increased blood osmolality
|
| S |
RHA/N-di |
Roman high avoidance-di mutation |
|
|
IED |
|
|
|
RGD:2314670 |
RGD |
increased blood urea nitrogen level
|
| Q |
Kidm8 |
Kidney mass QTL 8 |
|
|
QTM |
5 |
35,474,610 |
80,474,610 |
RGD:629573 |
RGD |
| S |
PCK/CrljCrl-Pkhd1pck/Crl |
|
|
|
IED |
|
|
|
RGD:628435 |
RGD |
increased circulating aldosterone level
|
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
|
IAGP |
7 |
113,043,365 |
113,049,779 |
RGD:727991 |
RGD |
| Q |
Sald1 |
Serum aldosterone level QTL 1 |
|
|
QTM |
17 |
1 |
24,981,037 |
RGD:629577 |
RGD |
| Q |
Sald2 |
Serum aldosterone level QTL 2 |
|
|
QTM |
18 |
54,856,551 |
72,450,442 |
RGD:629577 |
RGD |
| S |
BC/CpbU |
|
|
|
QTM |
|
|
|
RGD:629577 |
RGD |
increased circulating angiotensinogen level
|
| S |
LEW-Tg(Ren2)27 |
|
|
|
IED |
|
|
|
RGD:2293121 |
RGD |
| S |
SHRSP-Tg(Tagln-ACE2)6918Bdr |
|
|
|
IED |
|
|
|
RGD:2302131 |
RGD |
increased circulating atrial natriuretic factor
|
| Q |
Lanf1 |
Left ventricular atrial natriuretic factor QTL 1 |
|
|
QTM |
5 |
157,691,737 |
173,096,209 |
RGD:619659 |
RGD |
increased circulating bilirubin level
|
| S |
LEC |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
R |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
increased circulating cholesterol level
|
| Q |
Bw116 |
Body weight QTL 116 |
|
|
QTM |
1 |
229,876,870 |
267,593,558 |
RGD:619669 |
RGD |
| Q |
Iddm18 |
Insulin dependent diabetes mellitus QTL 18 |
|
|
QTM |
6 |
121,381,065 |
135,964,844 |
RGD:619685 |
RGD |
| Q |
Niddm57 |
Non-insulin dependent diabetes mellitus QTL 57 |
|
|
QTM |
1 |
229,876,870 |
267,593,558 |
RGD:619679 |
RGD |
| Q |
Scl11 |
Serum cholesterol level QTL 11 |
|
|
QTM |
14 |
19,110,728 |
38,152,541 |
RGD:619656 |
RGD |
| Q |
Scl14 |
Serum cholesterol level QTL 14 |
|
|
QTM |
5 |
115,772,027 |
160,772,027 |
RGD:737694 |
RGD |
| Q |
Scl15 |
Serum cholesterol level QTL 15 |
|
|
QTM |
5 |
35,474,610 |
80,474,610 |
RGD:737694 |
RGD |
| Q |
Scl16 |
Serum cholesterol level QTL 16 |
|
|
QTM |
8 |
33,897,608 |
78,897,608 |
RGD:737694 |
RGD |
| Q |
Scl17 |
Serum cholesterol level QTL 17 |
|
|
QTM |
2 |
221,002,002 |
258,207,540 |
RGD:737694 |
RGD |
| Q |
Scl19 |
Serum cholesterol QTL 19 |
|
|
QTM |
1 |
90,306,033 |
124,749,065 |
RGD:1299960 |
RGD |
| Q |
Scl22 |
Serum cholesterol level QTL 22 |
|
|
QTM |
18 |
12,406,571 |
32,459,145 |
RGD:61055 |
RGD |
| Q |
Scl25 |
Serum cholesterol level QTL 25 |
|
|
IAGP |
1 |
94,473,940 |
134,980,682 |
RGD:70849 |
RGD |
| Q |
Scl26 |
Serum cholesterol QTL 26 |
|
|
IAGP |
5 |
45,499,364 |
90,620,456 |
RGD:70849 |
RGD |
| Q |
Scl28 |
Serum cholesterol level QTL 28 |
|
|
IAGP |
18 |
12,406,975 |
25,621,024 |
RGD:70849 |
RGD |
| Q |
Scl29 |
Serum cholesterol level QTL 29 |
|
|
IAGP |
6 |
35,883,625 |
74,436,995 |
RGD:737686 |
RGD |
| Q |
Scl30 |
Serum cholesterol level QTL 30 |
|
|
IAGP |
7 |
21,790,655 |
53,398,255 |
RGD:1302893 |
RGD |
| Q |
Scl31 |
Serum cholesterol level QTL 31 |
|
|
IAGP |
17 |
26,570,057 |
71,570,057 |
RGD:1302893 |
RGD |
| Q |
Scl33 |
Serum cholesterol QTL 33 |
|
|
IED |
8 |
89,742,772 |
129,041,809 |
RGD:1299960 |
RGD |
| Q |
Scl34 |
Serum cholesterol QTL 34 |
|
|
IED |
1 |
184,857,716 |
223,729,371 |
RGD:1299960 |
RGD |
| Q |
Scl35 |
Serum cholesterol QTL 35 |
|
|
IED |
5 |
30,606,308 |
75,606,308 |
RGD:1299960 |
RGD |
| Q |
Scl36 |
Serum cholesterol QTL 36 |
|
|
IED |
1 |
53,013,200 |
90,306,478 |
RGD:1299960 |
RGD |
| Q |
Scl4 |
Serum cholesterol level QTL 4 |
|
|
QTM |
4 |
96,867,443 |
141,867,443 |
RGD:619667 |
RGD |
| Q |
Scl44 |
Serum cholesterol level QTL 44 |
|
|
IAGP |
5 |
41,498,818 |
155,121,024 |
RGD:1547851 |
RGD |
| Q |
Scl45 |
Serum cholesterol level QTL 45 |
|
|
IAGP |
14 |
66,611,911 |
101,647,208 |
RGD:1547851 |
RGD |
| Q |
Scl46 |
Serum cholesterol level QTL 46 |
|
|
IAGP |
4 |
135,601,855 |
180,601,855 |
RGD:1547851 |
RGD |
| Q |
Scl47 |
Serum cholesterol level QTL 47 |
|
|
IAGP |
10 |
54,091,148 |
99,091,148 |
RGD:1547851 |
RGD |
| Q |
Scl48 |
Serum cholesterol level QTL 48 |
|
|
IAGP |
12 |
10,716,230 |
46,782,294 |
RGD:1547851 |
RGD |
| Q |
Scl6 |
Serum cholesterol level QTL 6 |
|
|
QTM |
1 |
71,659,707 |
90,282,193 |
RGD:629577 |
RGD |
| Q |
Scl60 |
Serum cholesterol level QTL 60 |
|
|
IED |
5 |
150,236,110 |
167,844,737 |
RGD:619689 |
RGD |
| Q |
Scl61 |
Serum cholesterol level QTL 61 |
|
|
IED |
17 |
33,639,527 |
62,009,961 |
RGD:619689 |
RGD |
| Q |
Scl66 |
Serum cholesterol level QTL 66 |
|
|
IED |
8 |
32,203,499 |
110,106,272 |
RGD:2316856 |
RGD |
| Q |
Scl67 |
Serum cholesterol level QTL 67 |
|
|
QTM |
1 |
226,083,572 |
267,910,886 |
RGD:619669 |
RGD |
| Q |
Scl7 |
Serum cholesterol level QTL 7 |
|
|
QTM |
7 |
42,112,081 |
87,112,081 |
RGD:629577 |
RGD |
| Q |
Scl8 |
Serum cholesterol level QTL8 |
|
|
QTM |
2 |
224,795,742 |
258,207,540 |
RGD:629577 |
RGD |
| Q |
Scl9 |
Serum cholesterol level QTL 9 |
|
|
QTM |
16 |
16,194,598 |
22,671,959 |
RGD:629577 |
RGD |
| Q |
Stl25 |
Serum triglyceride level QTL 25 |
|
|
QTM |
1 |
184,857,716 |
216,663,271 |
RGD:1299960 |
RGD |
| S |
BBDR.LA-(D5Rat98-D5Rat233), BBDP-(D4Mit6-D4Mit7)/Rhw |
|
|
|
IED |
|
|
|
RGD:6893459 |
RGD |
| S |
BC/CpbU |
|
|
|
QTM |
|
|
|
RGD:629577 |
RGD |
| S |
BC/CpbU |
|
|
|
IED |
|
|
|
RGD:629577 |
RGD |
| S |
DA/K |
Dark Agouti/Karlsburg |
|
|
QTM |
|
|
|
RGD:1357168 |
RGD |
| S |
EHC/Seac |
|
|
|
IED |
|
|
|
RGD:2300117 |
RGD |
| S |
HTG |
Prague hypertriglyceridemic |
|
|
QTM |
|
|
|
RGD:1299960 |
RGD |
| S |
LH/Mav |
|
|
|
IED |
|
|
|
RGD:1580389 |
RGD |
| S |
SHRSP.ZUC-(D5Rat4-D5Rat36)/IzmDmcr |
|
|
|
IED |
|
|
|
RGD:2300017 |
RGD |
| S |
SS/Hsd |
|
|
|
QTM |
|
|
|
RGD:737694 |
RGD |
| S |
SS/JrHsdMcwi |
|
|
|
IED |
|
|
|
RGD:727992 |
RGD |
| S |
SS/JrRkb |
|
|
Induced |
IED |
|
|
|
RGD:2307185 |
RGD |
increased circulating corticosterone level
|
| G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
|
IAGP |
7 |
113,043,365 |
113,049,779 |
RGD:727991 |
RGD |
| Q |
Srcrt1 |
Stress Responsive Cort QTL1 |
|
|
IED |
2 |
167,857,161 |
231,465,091 |
RGD:1598980 |
RGD |
| Q |
Srcrt5 |
Stress Responsive Cort QTL 5 |
|
|
IED |
15 |
106,152,589 |
107,060,711 |
RGD:1598980 |
RGD |
| Q |
Stresp4 |
Stress response QTL 4 |
|
|
QTM |
4 |
47,889,730 |
149,560,340 |
RGD:737981 |
RGD |
| Q |
Stresp5 |
Stress response QTL 5 |
|
|
QTM |
10 |
43,458,380 |
108,776,963 |
RGD:737981 |
RGD |
| S |
BC/CpbU |
|
|
|
QTM |
|
|
|
RGD:629577 |
RGD |
| S |
ISIAH |
Inherited stress-induced arterial hypertension |
|
|
IED |
|
|
|
RGD:2306974 |
RGD |
| S |
WOKW/K |
|
|
Induced |
IED |
|
|
|
RGD:1642517 |
RGD |
increased circulating creatinine level
|
| S |
LEW-Tg(Ren2)27 |
|
|
|
IED |
|
|
|
RGD:2293121 |
RGD |
| S |
SBH-Chr 1SBN/Ygl |
|
|
|
IED |
|
|
|
RGD:629619 |
RGD |
| S |
SBH/Ygl |
Sabra hypertension prone |
|
|
IED |
|
|
|
RGD:629619 |
RGD |
| S |
SS/JrHsdMcwi |
|
|
|
IED |
|
|
|
RGD:727992 |
RGD |
increased circulating free fatty acid level
|
| G |
Gck |
glucokinase |
|
|
IED |
14 |
86,572,518 |
86,587,723 |
RGD:2301945 |
RGD |
| S |
SHR.PD-(D8Mgh9-D8Rat149)/Cub |
|
|
Induced |
IED |
8 |
58,692,901 |
58,693,265 |
RGD:1600413 |
RGD |
increased circulating glucagon level
|
| G |
Gcgr |
glucagon receptor |
|
|
IEA |
10 |
109,921,411 |
109,929,577 |
RGD:704404 |
RGD |
increased circulating glucose level
|
| Q |
Bw115 |
Body weight QTL 115 |
|
|
QTM |
1 |
240,980,321 |
267,110,921 |
RGD:61072 |
RGD |
| Q |
Bw120 |
Body weight QTL 120 |
|
|
QTM |
12 |
12,770,194 |
42,387,195 |
RGD:61083 |
RGD |
| Q |
Gluco18 |
Glucose level QTL 18 |
|
|
IAGP |
1 |
79,749,065 |
124,749,065 |
RGD:1580752 |
RGD |
| Q |
Gluco19 |
Glucose level QTL 19 |
|
|
IAGP |
9 |
91,131,330 |
99,799,902 |
RGD:1580752 |
RGD |
| Q |
Gluco20 |
Glucose level QTL 20 |
|
|
IAGP |
14 |
78,978,644 |
99,080,020 |
RGD:1580752 |
RGD |
| Q |
Gluco21 |
Glucose level QTL 21 |
|
|
IAGP |
2 |
121,545,310 |
163,154,358 |
RGD:1580752 |
RGD |
| Q |
Gluco22 |
Glucose level QTL 22 |
|
|
IAGP |
14 |
78,978,644 |
99,080,020 |
RGD:1580752 |
RGD |
| Q |
Gluco23 |
Glucose level QTL 23 |
|
|
IAGP |
14 |
76,579,917 |
112,194,335 |
RGD:1580752 |
RGD |
| Q |
Gluco24 |
Glucose level QTL 24 |
|
|
IAGP |
15 |
10,138,595 |
55,138,595 |
RGD:1580752 |
RGD |
| Q |
Gluco25 |
Glucose level QTL 25 |
|
|
IAGP |
4 |
84,886,545 |
151,158,853 |
RGD:1580752 |
RGD |
| Q |
Gluco26 |
Glucose level QTL 26 |
|
|
IAGP |
14 |
78,978,644 |
102,509,397 |
RGD:1580752 |
RGD |
| Q |
Gluco27 |
Glucose level QTL 27 |
|
|
IAGP |
14 |
78,978,644 |
99,080,020 |
RGD:1580752 |
RGD |
| Q |
Gluco28 |
Glucose level QTL 28 |
|
|
IAGP |
15 |
32,638,412 |
89,569,864 |
RGD:1580752 |
RGD |
| Q |
Gluco29 |
Glucose level QTL 29 |
|
|
IAGP |
14 |
78,978,644 |
99,080,020 |
RGD:1580752 |
RGD |
| Q |
Gluco30 |
Glucose level QTL 30 |
|
|
IAGP |
15 |
32,638,412 |
89,569,864 |
RGD:1580752 |
RGD |
| Q |
Gluco31 |
Glucose level QTL 31 |
|
|
QTM |
15 |
61,458,810 |
102,741,229 |
RGD:619656 |
RGD |
| Q |
Gluco32 |
Glucose level QTL 32 |
|
|
IED |
4 |
34,206,019 |
41,729,771 |
RGD:1626640 |
RGD |
| Q |
Gluco33 |
Glucose level QTL 33 |
|
|
IED |
7 |
13,170,547 |
32,454,105 |
RGD:1626640 |
RGD |
| Q |
Gluco34 |
Glucose level QTL 34 |
|
|
IED |
X |
41,386,788 |
62,894,306 |
RGD:1626640 |
RGD |
| Q |
Gluco35 |
Glucose level QTL 35 |
|
|
IEP |
3 |
79,283,621 |
114,574,752 |
RGD:2298688 |
RGD |
| Q |
Gluco36 |
Glucose level QTL 36 |
|
|
IEP |
8 |
30,878,636 |
53,049,477 |
RGD:2298688 |
RGD |
| Q |
Gluco37 |
Glucose level QTL 37 |
|
|
IEP |
13 |
1,265,159 |
47,698,301 |
RGD:2298688 |
RGD |
| Q |
Gluco38 |
Glucose level QTL 38 |
|
|
IEP |
14 |
12,386,493 |
30,087,990 |
RGD:2298688 |
RGD |
| Q |
Gluco39 |
Glucose level QTL 39 |
|
|
IED |
3 |
97,524,000 |
163,778,606 |
RGD:619689 |
RGD |
| Q |
Gluco40 |
Glucose level QTL 40 |
|
|
IED |
17 |
65,900,518 |
93,489,534 |
RGD:619689 |
RGD |
| Q |
Gluco42 |
Glucose level QTL 42 |
|
|
IED |
5 |
57,040,762 |
102,040,762 |
RGD:2312611 |
RGD |
| Q |
Gluco43 |
Glucose level QTL 43 |
|
|
IED |
8 |
29,077,622 |
74,077,622 |
RGD:2312611 |
RGD |
| Q |
Gluco45 |
Glucose level QTL 45 |
|
|
IED |
1 |
225,366,432 |
267,910,886 |
RGD:2312611 |
RGD |
| Q |
Gluco47 |
Glucose level QTL 47 |
|
|
IED |
5 |
12,890,569 |
57,890,569 |
RGD:2312611 |
RGD |
| Q |
Gluco48 |
Glucose level QTL 48 |
|
|
IED |
8 |
53,621,297 |
98,621,297 |
RGD:2312611 |
RGD |
| Q |
Gluco49 |
Glucose level QTL 49 |
|
|
IED |
17 |
61,100,283 |
97,296,363 |
RGD:2312611 |
RGD |
| Q |
Gluco50 |
Glucose level QTL 50 |
|
|
IED |
20 |
25,555,772 |
55,268,282 |
RGD:2312611 |
RGD |
| Q |
Gluco51 |
Glucose level QTL 51 |
|
|
IED |
1 |
225,366,432 |
267,910,886 |
RGD:2312611 |
RGD |
| Q |
Gluco53 |
Glucose level QTL 53 |
|
|
IED |
|
|
|
RGD:2312611 |
RGD |
| Q |
Gluco54 |
Glucose level QTL 54 |
|
|
IED |
9 |
1 |
42,602,240 |
RGD:2312611 |
RGD |
| Q |
Gluco55 |
Glucose level QTL 55 |
|
|
IED |
18 |
51,949,129 |
87,265,094 |
RGD:2312611 |
RGD |
| Q |
Gluco56 |
Glucose level QTL 56 |
|
|
IED |
1 |
205,040,948 |
207,483,209 |
RGD:2316693 |
RGD |
| Q |
Gluco57 |
Glucose level QTL 57 |
|
|
IED |
1 |
235,098,616 |
252,340,527 |
RGD:2316856 |
RGD |
| Q |
Gluco58 |
Glucose level QTL 58 |
|
|
IED |
4 |
6,690,606 |
185,398,530 |
RGD:2316856 |
RGD |
| Q |
Gluco59 |
Glucose level QTL 59 |
|
|
IED |
5 |
17,517,235 |
119,332,868 |
RGD:2316856 |
RGD |
| Q |
Gluco60 |
Glucose level QTL 60 |
|
|
IED |
10 |
14,721,135 |
154,166,503 |
RGD:2316856 |
RGD |
| Q |
Gluco61 |
Glucose level QTL 61 |
|
|
IED |
4 |
34,206,019 |
38,029,988 |
RGD:2326163 |
RGD |
| Q |
Gluco62 |
Glucose level QTL 62 |
|
|
IED |
11 |
56,625,258 |
67,465,962 |
RGD:2326163 |
RGD |
| Q |
Gluco63 |
Glucose level QTL 63 |
|
|
IED |
13 |
84,280,242 |
111,154,910 |
RGD:2326163 |
RGD |
| Q |
Iddm1 |
Insulin dependent diabetes mellitus QTL 1 |
|
|
QTM |
|
|
|
RGD:61076 |
RGD |
| Q |
Iddm10 |
Insulin dependent diabetes mellitus QTL 10 |
|
|
QTM |
1 |
178,054,386 |
201,472,944 |
RGD:6903877 |
RGD |
| Q |
Iddm11 |
Insulin dependent diabetes mellitus QTL 11 |
|
|
QTM |
4 |
56,920,444 |
78,042,833 |
RGD:61480 |
RGD |
| Q |
Iddm12 |
Insulin dependent diabetes mellitus QTL 12 |
|
|
QTM |
13 |
25,430,110 |
35,472,503 |
RGD:61480 |
RGD |
| Q |
Iddm13 |
Insulin dependent diabetes mellitus QTL 13 |
|
|
QTM |
3 |
131,188,558 |
163,778,754 |
RGD:61480 |
RGD |
| Q |
Iddm14 |
Insulin dependent diabetes mellitus QTL 14 |
|
|
QTM |
4 |
63,276,741 |
160,891,592 |
RGD:61479 |
RGD |
| Q |
Iddm2 |
Insulin dependent diabetes mellitus QTL 2 |
|
|
QTM |
|
|
|
RGD:61075 |
RGD |
| Q |
Iddm3 |
Insulin dependent diabetes mellitus QTL 3 |
|
|
QTM |
2 |
197,256,223 |
242,256,223 |
RGD:61075 |
RGD |
| Q |
Iddm4 |
Insulin dependent diabetes mellitus QTL 4 |
|
|
QTM |
18 |
41,165,704 |
86,165,704 |
RGD:61075 |
RGD |
| Q |
Iddm5 |
Insulin dependent diabetes mellitus QTL 5 |
|
|
IED |
X |
24,794,818 |
69,794,818 |
RGD:625443 |
RGD |
| Q |
Iddm6 |
Insulin dependent diabetes mellitus QTL 6 |
|
|
IED |
|
|
|
RGD:625443 |
RGD |
| Q |
Iddm7 |
Insulin dependent diabetes mellitus QTL 7 |
|
|
QTM |
|
|
|
RGD:631165 |
RGD |
| Q |
Iddm9 |
Insulin dependent diabetes mellitus QTL 9 |
|
|
IAGP |
1 |
247,322,146 |
266,002,939 |
RGD:6903877 |
RGD |
| Q |
Niddm12 |
Non-insulin dependent diabetes mellitus QTL 12 |
|
|
IED |
17 |
60,586,065 |
71,214,851 |
RGD:61061 |
RGD |
| Q |
Niddm14 |
Non-insulin dependent diabetes mellitus QTL 14 |
|
|
QTM |
7 |
90,478,161 |
135,478,161 |
RGD:61072 |
RGD |
| Q |
Niddm15 |
Non-insulin dependent diabetes mellitus QTL 15 |
|
|
QTM |
14 |
1,764,386 |
12,386,683 |
RGD:61072 |
RGD |
| Q |
Niddm16 |
Non-insulin dependent diabetes mellitus QTL 16 |
|
|
QTM |
X |
36,612,231 |
81,612,231 |
RGD:619678 |
RGD |
| Q |
Niddm2 |
Non-insulin dependent diabetes mellitus QTL 2 |
|
|
QTM |
2 |
152,256,313 |
197,256,313 |
RGD:61082 |
RGD |
| Q |
Niddm21 |
Non-insulin dependent diabetes mellitus QTL 21 |
|
Contributes_to |
IED |
8 |
3,039,822 |
61,462,321 |
RGD:2300331 |
RGD |
| Q |
Niddm3 |
Non-insulin dependent diabetes mellitus QTL 3 |
|
|
IED |
10 |
67,678,060 |
86,316,831 |
RGD:61082 |
RGD |
| Q |
Niddm37 |
Non-insulin dependent diabetes mellitus QTL 37 |
|
|
IED |
14 |
12,386,493 |
102,509,397 |
RGD:619676 |
RGD |
| Q |
Niddm38 |
Non-insulin dependent diabetes mellitus QTL 38 |
|
|
IED |
19 |
10,762,811 |
24,725,428 |
RGD:619676 |
RGD |
| Q |
Niddm39 |
Non-insulin dependent diabetes mellitus QTL 39 |
|
|
IED |
3 |
93,894,678 |
161,985,069 |
RGD:619676 |
RGD |
| Q |
Niddm45 |
Non-insulin dependent diabetes mellitus QTL 45 |
|
|
QTM |
1 |
146,971,983 |
176,854,992 |
RGD:619678 |
RGD |
| Q |
Niddm50 |
Non-insulin dependent diabetes mellitus QTL 50 |
|
|
QTM |
11 |
43,157,054 |
68,234,781 |
RGD:619678 |
RGD |
| Q |
Niddm6 |
Non-insulin dependent diabetes mellitus QTL 6 |
|
|
QTM |
16 |
4,304,396 |
52,304,351 |
RGD:61083 |
RGD |
| Q |
Niddm64 |
Non-insulin dependent diabetes mellitus QTL 64 |
|
|
IED |
1 |
254,291,806 |
254,810,043 |
RGD:1599587 |
RGD |
| Q |
Niddm66 |
Non-insulin dependent diabetes mellitus QTL 66 |
|
|
IED |
1 |
259,866,528 |
260,641,846 |
RGD:1599587 |
RGD |
| S |
BB.SHR-(D6Rat184-D6Rat101) |
|
|
|
QTM |
6 |
121,381,065 |
135,964,844 |
RGD:61077 |
RGD |
| S |
BB.SHR-(Gnal-D18Mit9) |
|
|
|
QTM |
18 |
63,595,606 |
80,370,517 |
RGD:619685 |
RGD |
| S |
BB/N |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
BBDP/Hri |
|
|
|
QTM |
|
|
|
RGD:61076 |
RGD |
| S |
BBDP/Rhw |
|
|
|
QTM |
|
|
|
RGD:61480 |
RGD |
| S |
BBDR.BBDP-(D4Mit6-D4Mit7)/1Rhw |
|
|
|
IED |
4 |
75,732,943 |
75,733,127 |
RGD:2293508 |
RGD |
| S |
BBDR.BBDP-(D4Mit6-D4Mit7)/2Rhw |
|
|
|
IED |
4 |
75,732,943 |
75,733,127 |
RGD:2293508 |
RGD |
| S |
BBDR.BBDP-(D4Mit6-D4Mit7)/3Rhw |
|
|
|
IED |
4 |
75,732,943 |
75,733,127 |
RGD:2293508 |
RGD |
| S |
BBDR/Rhw |
|
|
|
QTM |
|
|
|
RGD:61055 |
RGD |
| S |
BBZ |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
BN.GK-(D1Wox18-D1Got254)/Ox |
|
|
|
IED |
1 |
94,626,541 |
264,367,394 |
RGD:2300263 |
RGD |
| S |
CDS-Chr 4CDR/Ygl |
|
|
|
IED |
|
|
|
RGD:2326163 |
RGD |
| S |
CRDH |
Cohen Rosenthal Diabetic Hypertensive |
|
|
IED |
|
|
|
RGD:724741 |
RGD |
| S |
DA/K |
Dark Agouti/Karlsburg |
|
|
QTM |
|
|
|
RGD:1357168 |
RGD |
| S |
F344.GK-(D1Arb42a-D1Rat90)/Swe |
|
|
|
TAS |
1 |
267,110,921 |
267,111,153 |
RGD:1599587 |
RGD |
| S |
F344.OLETF-(D11Mgh4-D11Mgh1)/Tj |
|
|
|
TAS |
11 |
61,504,311 |
84,560,241 |
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D12Wox5-D12Rat21)/Tj |
|
|
|
TAS |
12 |
43,801,711 |
43,801,909 |
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D14Rat23-D14Rat12)(D14Rat8-D14Rat26)/Tj |
|
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D14Rat23-D14Rat12)(D8Rat54-D8Mgh17)/Tj |
|
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D14Rat23-D14Rat12)/Tj |
|
|
|
IED |
14 |
1,764,386 |
41,707,592 |
RGD:1643009 |
RGD |
| S |
F344.OLETF-(D14Rat8-D14Rat26)(D14Rat18-D14Rat22)/Tj |
|
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D14Rat8-D14Rat26)/Tj |
|
|
|
IED |
14 |
32,584,630 |
70,077,314 |
RGD:625760 |
RGD |
| S |
F344.OLETF-(D16Rat19-D16Rat13)/Tj |
|
|
|
TAS |
16 |
35,339,929 |
77,968,799 |
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D1Mit20-D1Mgh26)/Tj |
|
|
|
TAS |
1 |
94,356,875 |
176,616,212 |
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D1Rat166-D1Rat90)/Tj |
|
|
|
TAS |
1 |
255,026,793 |
267,111,153 |
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D5Mgh29-D5Mgh22)/Tj |
|
|
|
TAS |
5 |
157,584,332 |
157,584,492 |
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D5Mgh4-D5Rat21)/Tj |
|
|
|
TAS |
5 |
99,344,678 |
99,344,842 |
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D7Mgh16-D7Mgh20)(D14Rat23-D14Rat12)/Tj |
|
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D7Mgh16-D7Mgh20)(D14Rat8-D14Rat26)/Tj |
|
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D7Mgh16-D7Mgh20)/Tj |
|
|
|
IED |
7 |
103,612,739 |
123,191,874 |
RGD:1643009 |
RGD |
| S |
F344.OLETF-(D7Mgh8-D7Mgh16)(D14Rat23-D14Rat26)/Tj |
|
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D7Mit2-D7Mgh16)(D14Rat23-D14Rat26)/Tj |
|
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj |
|
|
|
IED |
|
|
|
RGD:1643009 |
RGD |
| S |
F344.OLETF-(D8Rat54-D8Mgh17)/Tj |
|
|
|
TAS |
8 |
19,796,514 |
73,102,155 |
RGD:1302502 |
RGD |
| S |
F344.OLETF-(D8Rat58-D8Mgh17)/Tj |
|
|
Contributes_to |
IED |
8 |
19,796,514 |
48,675,424 |
RGD:2300331 |
RGD |
| S |
F344.OLETF-(D9Mgh8-D9Mit2)/Tj |
|
|
|
TAS |
9 |
33,374,546 |
63,705,951 |
RGD:1302502 |
RGD |
| S |
F344.ZUC-Leprfa(D14Rat23-D14Rat12)/Tj |
|
|
|
TAS |
14 |
1,764,386 |
41,707,592 |
RGD:1302502 |
RGD |
| S |
F344.ZUC-Leprfa(D7Rat16-D7Mgh20)/Tj |
|
|
|
TAS |
7 |
108,647,236 |
108,647,376 |
RGD:1302502 |
RGD |
| S |
F344.ZUC-Leprfa/Tj |
|
|
|
TAS |
|
|
|
RGD:1302502 |
RGD |
| S |
F344/DuCrlCrlj |
|
|
|
QTM |
|
|
|
RGD:69696 |
RGD |
| S |
GK/KyoSwe |
Goto Kakizaki |
|
|
IED |
|
|
|
RGD:1303373 |
RGD |
| S |
GK/KyoSwe |
Goto Kakizaki |
|
|
QTM |
|
|
|
RGD:61061 |
RGD |
| S |
GK/Ox |
|
|
|
IED |
|
|
|
RGD:4889455 |
RGD |
| S |
LETL |
|
|
|
IED |
|
|
|
RGD:724731 |
RGD |
| S |
NMcwi:HS |
Heterogeneous stock |
|
|
IED |
|
|
|
RGD:2316693 |
RGD |
| S |
OLETF |
Otsuka Long-Evans Tokushima fatty |
|
|
QTM |
|
|
|
RGD:1004 |
RGD |
| S |
SD-Tg(Ins2-IAPP)Soel |
|
|
|
IED |
|
|
|
RGD:2313576 |
RGD |
| S |
SD-Tg(Insr-shRNA)14Bdr |
|
|
Induced |
IED |
|
|
|
RGD:2307333 |
RGD |
| S |
SD-Tg(Insr-shRNA)29Bdr |
|
|
Induced |
IED |
|
|
|
RGD:2307333 |
RGD |
| S |
SD/Rij |
|
|
|
IED |
|
|
|
RGD:628479 |
RGD |
| S |
SDT.ZDF-Leprfa/Jtt |
SDT fatty |
|
|
IED |
|
|
|
RGD:2314022 |
RGD |
| S |
SDT/CrljJcl |
|
|
|
IED |
|
|
|
RGD:628479 |
RGD |
| S |
SDT/Jcl |
|
|
|
QTM |
|
|
|
RGD:631173 |
RGD |
| S |
SHR |
Spontaneously Hypertensive Rat |
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
SHR-Tg(PEPCK-SREBF1)2Ipcv |
|
|
|
IED |
|
|
|
RGD:2313691 |
RGD |
| S |
SHR/NCruk |
Spontaneously Hypertensive Rat |
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
SHR/OlaIpcv-mtBN/Crl |
|
|
|
IED |
|
|
|
RGD:1627567 |
RGD |
| S |
SHRSP.ZUC-(D5Rat4-D5Rat36)/IzmDmcr |
|
|
|
IED |
|
|
|
RGD:2300017 |
RGD |
| S |
WBN |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
WDF |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
WF |
Wistar Furth |
|
|
QTM |
|
|
|
RGD:61480 |
RGD |
| S |
WF/Pit |
Wistar Furth |
|
|
QTM |
|
|
|
RGD:61480 |
RGD |
| S |
WKY |
|
|
|
QTM |
|
|
|
RGD:61050 |
RGD |
| S |
WOKW |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
ZDF |
Vancouver diabetic fatty Zucker |
|
|
IED |
|
|
|
RGD:68896 |
RGD |
increased circulating growth hormone level
|
| G |
Ghr |
growth hormone receptor |
|
|
IEA |
2 |
52,496,517 |
52,658,066 |
RGD:704404 |
RGD |
increased circulating HDL cholesterol level
|
| Q |
Scl12 |
Serum cholesterol level QTL 12 |
|
|
QTM |
19 |
14,981,499 |
32,108,153 |
RGD:61079 |
RGD |
| Q |
Scl13 |
Serum cholesterol level QTL 13 |
|
|
QTM |
|
|
|
RGD:61079 |
RGD |
| Q |
Scl23 |
Serum cholesterol level QTL 23 |
|
|
QTM |
4 |
1 |
22,959,087 |
RGD:61079 |
RGD |
| Q |
Scl27 |
Serum cholesterol level QTL 27 |
|
|
IAGP |
18 |
54,605,732 |
62,229,060 |
RGD:70849 |
RGD |
| Q |
Scl32 |
Serum cholesterol level QTL 32 |
|
|
IAGP |
17 |
26,570,057 |
71,570,057 |
RGD:1302893 |
RGD |
| S |
DA/K |
Dark Agouti/Karlsburg |
|
|
QTM |
|
|
|
RGD:1357168 |
RGD |
| S |
SS/Hsd |
|
|
|
QTM |
|
|
|
RGD:737694 |
RGD |
increased circulating insulin level
|
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
|
IED |
1 |
96,622,574 |
96,703,723 |
RGD:704366 |
RGD |
| Q |
Bw13 |
Body weight QTL 13 |
|
|
QTM |
X |
1 |
41,387,080 |
RGD:619682 |
RGD |
| Q |
Insul10 |
Insulin level QTL 10 |
|
|
IAGP |
|
|
|
RGD:1580752 |
RGD |
| Q |
Insul11 |
Insulin level QTL 11 |
|
|
IED |
1 |
146,971,846 |
247,322,277 |
RGD:619689 |
RGD |
| Q |
Insul12 |
Insulin level QTL 12 |
|
|
IED |
1 |
225,366,432 |
267,910,886 |
RGD:2312611 |
RGD |
| Q |
Insul13 |
Insulin level QTL 13 |
|
|
IED |
8 |
29,077,622 |
74,077,622 |
RGD:2312611 |
RGD |
| Q |
Insul14 |
Insulin level QTL 14 |
|
|
IED |
12 |
1 |
43,562,201 |
RGD:2312611 |
RGD |
| Q |
Insul15 |
Insulin level QTL 15 |
|
|
IED |
10 |
106,422,174 |
107,033,716 |
RGD:2312642 |
RGD |
| Q |
Insul16 |
Insulin level QTL 16 |
|
|
IED |
16 |
819,225 |
63,306,215 |
RGD:2312642 |
RGD |
| Q |
Insul4 |
Insulin level QTL 4 |
|
|
QTM |
X |
134,157,190 |
160,699,376 |
RGD:619682 |
RGD |
| Q |
Insul5 |
Insulin level QTL 5 |
|
|
IAGP |
17 |
15,245,341 |
29,604,237 |
RGD:1580752 |
RGD |
| Q |
Insul6 |
Insulin level QTL 6 |
|
|
IAGP |
|
|
|
RGD:1580752 |
RGD |
| Q |
Insul7 |
Insulin level QTL 7 |
|
|
IAGP |
|
|
|
RGD:1580752 |
RGD |
| Q |
Insul8 |
Insulin level QTL 8 |
|
|
IAGP |
16 |
1 |
26,804,456 |
RGD:1580752 |
RGD |
| Q |
Insul9 |
Insulin level QTL 9 |
|
|
IAGP |
|
|
|
RGD:1580752 |
RGD |
| Q |
Niddm11 |
Non-insulin dependent diabetes mellitus QTL 11 |
|
|
QTM |
|
|
|
RGD:61061 |
RGD |
| Q |
Niddm61 |
Non-insulin dependent diabetes mellitus QTL 61 |
|
|
IAGP |
8 |
38,003,289 |
103,665,018 |
RGD:1300044 |
RGD |
| Q |
Niddm62 |
Non-insulin dependent diabetes mellitus QTL 62 |
|
|
IAGP |
2 |
156,142,685 |
210,636,169 |
RGD:1302801 |
RGD |
| Q |
Niddm8 |
Non-insulin dependent diabetes mellitus QTL 8 |
|
|
QTM |
2 |
181,214,853 |
182,740,242 |
RGD:61061 |
RGD |
| Q |
Niddm9 |
Non-insulin dependent diabetes mellitus QTL 9 |
|
|
QTM |
|
|
|
RGD:61061 |
RGD |
| Q |
Stl4 |
Serum triglyceride level QTL 4 |
|
|
QTM |
4 |
72,160,227 |
134,858,710 |
RGD:631174 |
RGD |
| S |
BBDR.LA-(D5Rat98-D5Rat233), BBDP-(D4Mit6-D4Mit7)/Rhw |
|
|
|
IED |
|
|
|
RGD:6893459 |
RGD |
| S |
BN.GK-(D1Wox18-D1Got254)/Ox |
|
|
|
IED |
1 |
94,626,541 |
264,367,394 |
RGD:2300263 |
RGD |
| S |
CDS/Ygl |
Cohen diabetic-sensitive rat |
|
|
TAS |
|
|
|
RGD:1342468 |
RGD |
| S |
DA.WOKW-(D10Mgh2-D10Rat4)/K |
|
|
|
IED |
10 |
106,422,174 |
107,033,716 |
RGD:2312642 |
RGD |
| S |
DA.WOKW-(D16Rat88-D16Wox7)/K |
|
|
|
IED |
16 |
819,225 |
63,306,215 |
RGD:2312642 |
RGD |
| S |
GK/KyoSwe |
Goto Kakizaki |
|
|
TAS |
|
|
|
RGD:61082 |
RGD |
| S |
GK/Ox |
|
|
|
IED |
|
|
|
RGD:4889455 |
RGD |
| S |
HTG |
Prague hypertriglyceridemic |
|
|
TAS |
|
|
|
RGD:1303386 |
RGD |
| S |
HTG |
Prague hypertriglyceridemic |
|
|
IED |
|
|
|
RGD:1342424 |
RGD |
| S |
LA/N-cp |
|
|
|
TAS |
|
|
|
RGD:6893459 |
RGD |
| S |
LH/Mav |
|
|
|
IED |
|
|
|
RGD:1580389 |
RGD |
| S |
OLETF |
Otsuka Long-Evans Tokushima fatty |
|
|
QTM |
|
|
|
RGD:1004 |
RGD |
| S |
OLETF/Got |
Otsuka Long Evans Tokushima |
|
|
IED |
|
|
|
RGD:619679 |
RGD |
| S |
SD-Tg(Ins2-IAPP)Soel |
|
|
|
IED |
|
|
|
RGD:2313576 |
RGD |
| S |
SD-Tg(Insr-shRNA)14Bdr |
|
|
Induced |
IED |
|
|
|
RGD:2307333 |
RGD |
| S |
SD-Tg(Insr-shRNA)29Bdr |
|
|
Induced |
IED |
|
|
|
RGD:2307333 |
RGD |
| S |
SHR-Tg(PEPCK-SREBF1)2Ipcv |
|
|
|
IED |
|
|
|
RGD:2313691 |
RGD |
| S |
SHR/OlaIpcv-mtBN/Crl |
|
|
|
IED |
|
|
|
RGD:1627567 |
RGD |
| S |
SHRSP.ZUC-(D5Rat4-D5Rat36)/IzmDmcr |
|
|
|
IED |
|
|
|
RGD:2300017 |
RGD |
| S |
WDF |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
WOKW |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
WOKW |
|
|
|
QTM |
|
|
|
RGD:1357168 |
RGD |
| S |
ZUC-LeprfaSteJrpz |
|
|
|
IED |
|
|
|
RGD:628436 |
RGD |
increased circulating ketone body level
|
| S |
BB/N |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
BBDP/WorN |
|
|
|
IED |
|
|
|
RGD:1578691 |
RGD |
| S |
BBZ |
|
|
|
TAS |
|
|
|
RGD:1004 |
RGD |
| S |
LETL |
|
|
|
IED |
|
|
|
RGD:724731 |
RGD |
increased circulating LDL cholesterol level
|
| Q |
Scl18 |
Serum cholesterol level QTL 18 |
|
|
QTM |
5 |
84,392,127 |
129,392,127 |
RGD:737694 |
RGD |
| S |
BN.PD-(D8Rat39-D8Rat35),SHR-(D2Mit4-D2Rat28),SHR-(D2Rat103-D2Rat107)/Cub |
|
|
|
IED |
|
|
|
RGD:1580751 |
RGD |
| S |
SS/Hsd |
|
|
|
QTM |
|
|
|
RGD:737694 |
RGD |
increased circulating leptin level
|
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
|
IAGP |
2 |
93,536,133 |
93,540,734 |
RGD:737686 |
RGD |
| Q |
Slep1 |
Serum leptin concentration QTL 1 |
|
|
IAGP |
2 |
42,882,523 |
191,378,271 |
RGD:737686 |
RGD |
| Q |
Slep2 |
Serum leptin concentration QTL 2 |
|
|
IAGP |
6 |
1,301,952 |
74,436,995 |
RGD:737686 |
RGD |
| Q |
Slep3 |
Serum leptin concentration QTL 3 |
|
|
IAGP |
8 |
9,581,375 |
44,484,215 |
RGD:1357168 |
RGD |
| Q |
Slep4 |
Serum leptin concentration QTL 4 |
|
|
IAGP |
16 |
9,964,433 |
30,560,825 |
RGD:1357168 |
RGD |
| Q |
Slep5 |
Serum leptin concentration QTL 5 |
|
|
IED |
8 |
9,581,375 |
44,484,215 |
RGD:619689 |
RGD |
| Q |
Slep6 |
Serum leptin concentration QTL 6 |
|
|
IED |
16 |
1 |
32,464,321 |
RGD:619689 |
RGD |
| Q |
Slep7 |
Serum leptin concentration QTL 7 |
|
|
IED |
3 |
97,523,869 |
170,016,653 |
RGD:2312642 |
RGD |
| Q |
Slep8 |
Serum leptin concentration QTL 8 |
|
|
IED |
10 |
106,422,174 |
107,033,716 |
RGD:2312642 |
RGD |
| Q |
Slep9 |
Serum leptin concentration QTL 9 |
|
|
IED |
16 |
819,225 |
63,306,215 |
RGD:2312642 |
RGD |
| S |
BBDR.LA-(D5Rat98-D5Rat233), BBDP-(D4Mit6-D4Mit7)/Rhw |
|
|
|
IED |
|
|
|
RGD:6893459 |
RGD |
| S |
DA.WOKW-(D10Mgh2-D10Rat4)/K |
|
|
|
IED |
10 |
106,422,174 |
107,033,716 |
RGD:2312642 |
RGD |
| S |
DA.WOKW-(D16Rat88-D16Wox7)/K |
|
|
|
IED |
16 |
819,225 |
63,306,215 |
RGD:2312642 |
RGD |
| S |
DA.WOKW-(D3Mgh5-D3Rat1)/K |
|
|
|
IED |
3 |
97,523,869 |
170,016,653 |
RGD:2312642 |
RGD |
| S |
SDT.ZDF-Leprfa/Jtt |
SDT fatty |
|
|
IED |
|
|
|
RGD:2314022 |
RGD |
| S |
SHRSP.ZUC-(D5Rat4-D5Rat36)/IzmDmcr |
|
|
|
IED |
|
|
|
RGD:2300017 |
RGD |
| S |
WOKW |
|
|
|
QTM |
|
|
|
RGD:1357168 |
RGD |
increased circulating luteinizing hormone level
|
| S |
HAA/FDSC |
Hatano High Avoidance |
|
|
TAS |
|
|
|
RGD:1300227 |
RGD |
increased circulating noradrenaline level
|
| Q |
Cstrr1 |
Cold stress response QTL 1 |
|
|
QTM |
1 |
124,614,679 |
187,092,492 |
RGD:1302892 |
RGD |
| Q |
Cstrr2 |
Cold stress response QTL 2 |
|
|
IED |
1 |
158,964,262 |
160,755,065 |
RGD:4889147 |
RGD |
| Q |
Stresp24 |
Stress response QTL 24 |
|
|
IED |
1 |
158,964,262 |
160,755,065 |
RGD:4889147 |
RGD |
| Q |
Stresp6 |
Stress response QTL 6 |
|
|
IAGP |
10 |
36,649,906 |
65,379,965 |
RGD:1332590 |
RGD |
| Q |
Stresp7 |
Stress response QTL 7 |
|
|
IAGP |
10 |
68,955,627 |
113,955,627 |
RGD:1332590 |
RGD |
| S |
MNRA/N |
|
|
|
TAS |
|
|
|
RGD:1358541 |
RGD |
| S |
WKY.SHRSP-(D1Wox29-D1Arb21)/Izm |
|
|
|
QTM |
1 |
124,614,679 |
187,092,492 |
RGD:1302892 |
RGD |
increased circulating phospholipid level
|
| S |
LH/Mav |
|
|
|
IED |
|
|
|
RGD:1580389 |
RGD |
increased circulating prolactin level
|
| S |
ACI/SegHsd |
|
|
Induced |
IED |
|
|
|
RGD:1642526 |
RGD |
increased circulating renin level
|
| Q |
Srn4 |
Serum renin concentration QTL 4 |
|
|
IAGP |
1 |
33,134,446 |
78,134,446 |
RGD:70849 |
RGD |
| S |
F344-Tg(Cyp1a1-Ren2)10Jmul |
|
|
Induced |
IED |
|
|
|
RGD:2302140 |
RGD |
| S |
F344-Tg(Cyp1a1-Ren2)10Jmul |
|
|
Induced |
IED |
|
|
|
RGD:2313695 |
RGD |
| S |
F344.LEW-(D10Rat142-D10Rat15)/Jmul |
|
|
Induced |
IED |
10 |
92,448,353 |
96,667,338 |
RGD:2313695 |
RGD |
| S |
LEW-Chr YF344/Jmul |
|
|
Induced |
IED |
|
|
|
RGD:2313695 |
RGD |
| S |
LEW.F344-(D10Rat99-D10Rat11)/Jmul |
|
|
Induced |
IED |
10 |
89,278,229 |
100,633,982 |
RGD:2313695 |
RGD |
| S |
SS.BN-(D13Rat123-D13Rat101)/Mcwi |
|
|
Induced |
IED |
13 |
44,872,181 |
49,428,577 |
RGD:2289092 |
RGD |
increased circulating serum albumin level
|
| S |
SS-Rag1em1Mcwi |
|
|
|
IED |
|
|
|
RGD:7207429 |
RGD |
| S |
SS-Rag1em2Mcwi |
|
|
|
IED |
|
|
|
RGD:7207429 |
RGD |
increased circulating thyroid-stimulating hormone level
|
| Q |
Thshl1 |
Thyroid stimulating hormone level QTL 1 |
|
|
IAGP |
6 |
93,373,975 |
111,239,430 |
RGD:1302891 |
RGD |
| Q |
Thshl2 |
Thyroid stimulating hormone level QTL 2 |
|
|
IAGP |
5 |
101,506,332 |
154,014,139 |
RGD:1302891 |
RGD |
increased circulating total protein level
|
| Q |
Spl3 |
Serum phospholipid level QTL 3 |
|
|
QTM |
18 |
32,459,145 |
80,370,367 |
RGD:61055 |
RGD |
increased circulating triglyceride level
|
| G |
Gck |
glucokinase |
|
|
IED |
14 |
86,572,518 |
86,587,723 |
RGD:2301945 |
RGD |
| Q |
Hrtrt8 |
Heart rate QTL 8 |
|
|
QTM |
5 |
2,965,857 |
49,767,421 |
RGD:727992 |
RGD |
| Q |
Iddm18 |
Insulin dependent diabetes mellitus QTL 18 |
|
|
QTM |
6 |
121,381,065 |
135,964,844 |
RGD:619685 |
RGD |
| Q |
Scl5 |
Serum cholesterol level QTL 5 |
|
|
QTM |
1 |
243,502,887 |
267,910,886 |
RGD:619667 |
RGD |
| Q |
Stl1 |
Serum triglyceride level QTL 1 |
|
|
QTM |
|
|
|
RGD:619656 |
RGD |
| Q |
Stl10 |
Serum triglyceride level QTL 10 |
|
|
IAGP |
4 |
17,617,956 |
41,729,771 |
RGD:737686 |
RGD |
| Q |
Stl11 |
Serum triglyceride level QTL 11 |
|
|
IAGP |
7 |
126,748,283 |
143,002,779 |
RGD:737686 |
RGD |
| Q |
Stl12 |
Serum triglyceride level QTL 12 |
|
|
IAGP |
11 |
68,234,781 |
87,759,784 |
RGD:737686 |
RGD |
| Q |
Stl13 |
Serum triglyceride level QTL 13 |
|
|
IAGP |
17 |
27,118,351 |
71,570,057 |
RGD:1302893 |
RGD |
| Q |
Stl14 |
Serum triglyceride level QTL 14 |
|
|
IAGP |
7 |
119,494,698 |
141,116,327 |
RGD:1357168 |
RGD |
| Q |
Stl17 |
Serum triglyceride level QTL 17 |
|
|
IAGP |
7 |
74,244,916 |
119,494,569 |
RGD:1357168 |
RGD |
| Q |
Stl19 |
Serum triglyceride level QTL 19 |
|
|
IAGP |
4 |
460,493 |
64,750,077 |
RGD:1357415 |
RGD |
| Q |
Stl2 |
Serum triglyceride level QTL 2 |
|
|
QTM |
4 |
461,376 |
54,828,069 |
RGD:619667 |
RGD |
| Q |
Stl20 |
Serum triglyceride level QTL 20 |
|
|
IAGP |
8 |
51,577,566 |
52,065,790 |
RGD:1580752 |
RGD |
| Q |
Stl21 |
Serum triglyceride level QTL 21 |
|
|
IAGP |
15 |
32,638,412 |
89,569,864 |
RGD:1580752 |
RGD |
| Q |
Stl22 |
Serum triglyceride level QTL 22 |
|
|
IED |
4 |
460,493 |
55,370,202 |
RGD:619689 |
RGD |
| Q |
Stl23 |
Serum triglyceride level QTL 23 |
|
|
IED |
16 |
819,225 |
63,306,215 |
RGD:2312642 |
RGD |
| Q |
Stl24 |
Serum triglyceride level QTL 24 |
|
|
IED |
7 |
72,552,109 |
120,746,007 |
RGD:2316856 |
RGD |
| Q |
Stl25 |
Serum triglyceride level QTL 25 |
|
|
QTM |
1 |
184,857,716 |
216,663,271 |
RGD:1299960 |
RGD |
| Q |
Stl26 |
Serum triglyceride level QTL 26 |
|
|
QTM |
2 |
212,168,913 |
242,131,387 |
RGD:1299960 |
RGD |
| Q |
Stl27 |
Serum triglyceride level QTL 27 |
|
|
QTM |
2 |
24,474,447 |
148,790,758 |
RGD:1299960 |
RGD |
| Q |
Stl29 |
Serum triglyceride level QTL 29 |
|
|
IED |
13 |
88,260,176 |
90,551,272 |
RGD:1299960 |
RGD |
| Q |
Stl29 |
Serum triglyceride level QTL 29 |
|
|
QTM |
13 |
88,260,176 |
90,551,272 |
RGD:1299960 |
RGD |
| Q |
Stl30 |
Serum triglyceride level QTL 30 |
|
|
IED |
16 |
28,455,247 |
73,455,247 |
RGD:1299960 |
RGD |
| Q |
Stl31 |
Serum triglyceride level QTL 31 |
|
|
QTM |
1 |
244,611,037 |
267,910,886 |
RGD:619669 |
RGD |
| Q |
Stl4 |
Serum triglyceride level QTL 4 |
|
|
QTM |
4 |
72,160,227 |
134,858,710 |
RGD:631174 |
RGD |
| Q |
Stl5 |
Serum triglyceride level QTL 5 |
|
|
QTM |
8 |
28,414,004 |
58,991,068 |
RGD:631174 |
RGD |
| Q |
Stl6 |
Serum triglyceride level QTL 6 |
|
|
QTM |
8 |
64,616,911 |
116,844,692 |
RGD:631174 |
RGD |
| Q |
Stl7 |
Serum triglyceride level QTL 7 |
|
|
QTM |
11 |
29,744,366 |
84,560,241 |
RGD:727992 |
RGD |
| Q |
Stl8 |
Serum triglyceride level QTL 8 |
|
|
QTM |
1 |
230,963,695 |
267,910,886 |
RGD:70852 |
RGD |
| Q |
Stl9 |
Serum triglyceride level QTL 9 |
|
|
QTM |
8 |
44,484,347 |
74,178,405 |
RGD:70852 |
RGD |
| S |
HTG |
Prague hypertriglyceridemic |
|
|
TAS |
|
|
|
RGD:1303386 |
RGD |
| S |
LA/N-cp |
|
|
|
TAS |
|
|
|
RGD:6893459 |
RGD |
| S |
SHR-Tg(PEPCK-SREBF1)2Ipcv |
|
|
|
IED |
|
|
|
RGD:2313691 |
RGD |
| S |
SHRSP.ZUC-(D5Rat4-D5Rat36)/IzmDmcr |
|
|
|
IED |
|
|
|
RGD:2300017 |
RGD |
| S |
SHRSP/A3 |
|
|
|
TAS |
|
|
|
RGD:61092 |
RGD |
| S |
SS-Tg(ApoC3-CETP)53Opaz |
|
|
|
IED |
|
|
|
RGD:2290427 |
RGD |
| S |
SS/Hsd |
|
|
|
QTM |
|
|
|
RGD:737694 |
RGD |
| S |
SS/JrHsdMcwi |
|
|
|
IED |
|
|
|
RGD:727992 |
RGD |
| S |
WOKW |
|
|
|
QTM |
|
|
|
RGD:1357168 |
RGD |
increased circulating VLDL cholesterol level
|
| Q |
Stl13 |
Serum triglyceride level QTL 13 |
|
|
IAGP |
17 |
27,118,351 |
71,570,057 |
RGD:1302893 |
RGD |
Term paths to the root
|